1. Home
  2. TRDA vs PEBK Comparison

TRDA vs PEBK Comparison

Compare TRDA & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$5.11

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo Peoples Bancorp of North Carolina Inc.

PEBK

Peoples Bancorp of North Carolina Inc.

N/A

Current Price

$43.52

Market Cap

230.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TRDA
PEBK
Founded
2016
1912
Country
United States
United States
Employees
N/A
276
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
230.7M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
TRDA
PEBK
Price
$5.11
$43.52
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $18.75
N/A
AVG Volume (30 Days)
★ 460.4K
57.4K
Earning Date
11-05-2026
10-19-2026
Dividend Yield
N/A
★ 1.94%
EPS Growth
N/A
★ 21.48
EPS
N/A
★ 2.81
Revenue
★ $25,421,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$709.43
N/A
P/E Ratio
★ N/A
$15.38
Revenue Growth
N/A
★ N/A
52 Week Low
$4.11
$29.31
52 Week High
$16.45
$45.78

Technical Indicators

Market Signals
Indicator
TRDA
PEBK
Relative Strength Index (RSI) 49.88 49.10
Support Level $4.18 $41.75
Resistance Level $5.13 $45.38
Average True Range (ATR) 0.49 1.38
MACD 0.12 -0.06
Stochastic Oscillator 68.02 56.98

Price Performance

Historical Comparison
TRDA
PEBK

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About PEBK Peoples Bancorp of North Carolina Inc.

Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.

Share on Social Networks: